Skip to main content
. 2010 Jun 10;1(2):131–147. doi: 10.18632/oncotarget.117

Figure 7. Immunocytochemistry of human breast carcinoma cases.

Figure 7.

(A) Classic DCIS (upper right) and adjacent lymphovascular tumor embolus (lower left) exhibits E-cadherin immunoreactivity. (B) The lymphovascular tumor embolus in A (higher magnification) exhibits E-cadherin immunoreactivity. (C) DCIS transitioning to possible LVI exhibits E-cadherin immunoreactivity. (D) DCIS exhibits Ki-67 immunoreactivity. (E) The lymphovascular tumor embolus (left) exhibits Ki-67 immunoreactivity.